About: Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era
Creator	Kumar, Dinesh Alagumanian, • Kasilingam, Dharun Prabhakaran, • Rajagopal, Varthini Santhosh Kumar, •
source	Medline; PMC
abstract	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the seventh-generation coronavirus family causing viral pandemic coronavirus disease (COVID-19) across globe affecting millions of people. The objectives of this study are to (1) identify the major research themes in COVID-19 literature, (2) determine the origin, symptoms and modes of transmission of COVID, (3) recommend the intervention and mitigation strategies adopted by the Governments globally against the spread of COVID-19 and the traumatization among the public? and (4) study the possible drugs/treatment plans against COVID-19. A systematic literature review and comprehensive analysis of 38 research articles on COVID-19 are conducted. An integrated Research focus parallel-ship network and keyword co-occurrence analysis are carried out to visualize the three research concepts in COVID-19 literature. Some of our observations include: (1) as SARS-CoV-2’s RNA matches ~ 96% to SARS-CoV, it is assumed to be transmitted from the bats. (2) The common symptoms are high fever, dry cough, fatigue, sputum production, shortness of breath, diarrhoea etc. (3) A lockdown across 180 affected counties for more than a month with social-distancing and the precautions taken in SARS and MERS are recommended by the Governments. (4) Researchers’ claim that nutrition and immunity enhancers and treatment plans such as arbidol, lopinavir/ritonavir, convalescent plasma and mesenchymal stem cells and drugs including remdesivir, hydroxychloroquine, azithromycin and favipiravir are effective against COVID-19. This complied report serves as guide to help the administrators, researchers and the medical officers to adopt recommended intervention strategies and the optimal treatment/drug against COVID-19. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s13337-020-00604-z) contains supplementary material, which is available to authorized users.
has issue date	2020-06-11(xsd:dateTime)
bibo:doi	10.1007/s13337-020-00604-z
bibo:pmid	32656310
has license	no-cc
sha1sum (hex)	5f9af633d3f974a3025d5096316dce7b9a35e4cc
schema:url	https://doi.org/10.1007/s13337-020-00604-z
resource representing a document's title	Systematic literature review on novel corona virus SARS-CoV-2: a threat to human era
has PubMed Central identifier	PMC7288266
has PubMed identifier	32656310
schema:publication	Virusdisease
resource representing a document's body	covid:5f9af633d3f974a3025d5096316dce7b9a35e4cc#body_text
is schema:about of	named entity 'matches' named entity 'co-occurrence' named entity 'favipiravir' named entity 'SARS-CoV' named entity 'hydroxychloroquine' named entity 'focus' named entity 'The' named entity 'seventh-generation' named entity 'corona virus' named entity 'MILLIONS' named entity 'PEOPLE' named entity '283' named entity 'NUTRITION' named entity 'PARALLEL' named entity 'RECOMMEND' named entity 'INTERVENTION' named entity 'DIARRHOEA' named entity 'SEVENTH' named entity 'KEYWORD' named entity 'INCLUDING' named entity 'COMMON' named entity 'HIGH FEVER' named entity 'COVID-19' named entity 'transmission' named entity 'fever' named entity 'breath' named entity 'causing' named entity 'production' named entity 'mitigation' named entity 'carried' named entity 'comprehensive' named entity 'traumatization' named entity 'globally' named entity 'conducted' named entity 'serves' named entity 'Research' named entity 'dry cough' named entity 'sputum production' named entity 'SARS-CoV-2' named entity 'co-occurrence' named entity 'remdesivir' named entity 'azithromycin' named entity 'RNA' named entity 'arbidol' named entity 'SARS' named entity 'Severe acute respiratory syndrome coronavirus 2' named entity 'COVID-19' named entity 'COVID-19' named entity 'diarrhoea' named entity 'high fever' named entity 'nutrition' named entity 'COVID' named entity 'corona virus' named entity 'SARS-CoV-2' named entity 'social-distancing' named entity 'systematic literature review' named entity 'human era' named entity 'viral pandemic' named entity 'fatigue' named entity 'COVID' named entity 'lopinavir/ritonavir' named entity 'The common' named entity 'bats' named entity 'immunity' named entity 'COVID-19' named entity 'MEDICAL OFFICERS' named entity 'SARS-COV' named entity 'favipiravir' named entity 'convalescent plasma' named entity 'MERS' named entity 'SARS-CoV-2' named entity 'shortness of breath' named entity 'lockdown' named entity 'mesenchymal stem cells' named entity 'coronavirus disease' named entity 'RECOMMENDED'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software